HIV Research Preview for ASM Microbe 2016: New Frontiers in Cure
June 14, 2016
This year, the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) combines with the American Society for Microbiology (ASM) General Meeting to form the all-new ASM Microbe 2016. The meeting begins June 16 in Boston, and TheBodyPRO.com will be on-site to provide news and analysis on the latest HIV and hepatitis C research.
But before we get there, here's a sneak peak at what's noteworthy on the agenda.
We continue to make progress toward a cure. This session will review where we stand currently and what strategies are being developed, including immune-based therapeutics, genetic engineering and next steps toward eradication. The session will also look at some of the latest insights into how our understanding of the HIV reservoir can further cure efforts.
A mainstay at every HIV conference, this session will examine the current state of antiretroviral therapy and patient care. The session will include presentations on what regimens to start in 2016, new antiretrovirals in the pipeline and the use of mobile technology to engage and retain patients. It will also ask whether we still need three drugs in treatment regimens.
Although we have a cure for hepatitis C (HCV), a recent report finds that [[HCV kills more Americans than any other infectious disease http://www.thebodypro.com/content/77540/hepatitis-c-kills-more-americans-than-any-other-in.html]]. Hopefully this session will shed some light on how to better address that problem by providing an update on the management of HCV (particularly for hard-to-treat populations), as well as addressing the challenges of actually implementing HCV treatment.
Warren Tong is the senior science editor for TheBody.com and TheBodyPRO.com. Follow Warren on Twitter: @WarrenAtTheBody.
This article was provided by TheBodyPRO. It is a part of the publication ASM Microbe 2016.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.